Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma

International Journal of Cancer

Volumn 95, Issue 3, 2001, Pages 168-175

  Bartel, Frank ^a   Meye, Axel ^b   Würl, Peter ^c   Kappler, Matthias ^a   Bache, Matthias ^a   Lautenschläger, Christine ^a   Grünbaum, Ulrich ^a   Schmidt, Hannelore ^a   Taubert, Helge ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Alternative splicing; Amplification; MRNA; Murine double minute 2 gene; Soft tissue sarcoma

Indexed keywords

ONCOPROTEIN;

ARTICLE; CANCER GRADING; CANCER SURVIVAL; DIAGNOSTIC VALUE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RNA SPLICING; SOFT TISSUE SARCOMA;

ALLELES; ALTERNATIVE SPLICING; GENE AMPLIFICATION; GENETIC MARKERS; HUMANS; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, MESSENGER; SARCOMA; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1042274013     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010520)95:3<168::AID-IJC1029>3.0.CO;2-A     Document Type: Article

References (41)

1. Cahilly-Snyder LT, Yang-Feng T, Francke U, George DL. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet 1987;13: 235-44.
2. Fakharzadeh SS, Trusko SP, George DL. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 1991;10:1565-9.
3. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992;358:80-3.
4. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 1993;53:16-8.
5. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, et al. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 1993;53:2231-4.
6. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 1993;53:2736-9.
7. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, et al. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994;54:794-9.
8. Meddeb M, Valent A, Danglot G, Nguyen VC, Duverger A, Fouquet F, et al. MDM2 amplification in a primary alveolar rhabdomyosarcoma displaying a t(2;13)(q35;q14). Cytogenet Cell Genet 1996;73: 325-30.
9. Momand J, Jung D, Wilczynski S, Niland J. The MDM2 gene amplification database. Nucleic Acids Res 1998;26:3453-9.
10. Piette J, Neel H, Marechal V. Mdm2: keeping p53 under control. Oncogene 1997;15:1001-10.
11. Momand J, Wu HH, Dasgupta G. MDM2 - master regulator of the p53 tumor suppressor protein. Gene 2000;242:15-29.
12. ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 1999;18:22-7.
13. Hsieh J-K, Chan FSG, O'Connor DJ, Mittnacht S, Zhong S, Lu X. RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell 1999;3:181-93.
14. Würl P, Meye A, Schmidt H, Lautenschläger C, Kalthoff H, Rath FW, et al. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities. Oncogene 1998;16:1183-5.
15. Buesos-Ramos CE, Yang Y, deLeon E, McCown P, Strass SA, Albitar M. The human MDM2 oncogene is overexpressed in leukemias. Blood 1993;82:2617-23.
16. Barak Y, Gottlieb E, Juven-Gershon T, Oren M. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translational potential. Genes Dev 1994;8:1739-49.
17. Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T, et al. The MDM2 oncogene overexpression in chronic lymphocytic and low-grade lymphoma of B-cell origin. Blood 1994;84:3158-65.
18. Landers JE, Haines DS, Strauss JF, George DL. Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene 1994;9:2745-50.
19. Landers JE, Cassel SL, George DL. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Cancer Res 1997;57:3562-8.
20. Pollock RE. Lang A, El-Naggar AK, Radinsky R, Hung MC. Enhanced mdm2 oncoprotein expression in soft tissue sarcomas: several possible mechanisms. Sarcoma 1997;1:23-9.
21. Taubert H, Koehler T, Meye A, Bartel F, Lautenschläger C, Borchert S, et al. mdm2 mRNA level is a prognostic factor in soft tissue sarcoma. Mol Med 2000;6:50-9.
22. Ko JL, Cheng YW, Chang SL, Su JM, Chen CY, Lee H. MDM2 mRNA Expression is a favorable prognostic factor in non-small-cell lung cancer. Int J Cancer 2000;89:265-70.
23. Schlott T, Reimer S, Jahns A, Ohlenbusch A, Ruschenberg I, Nagel H, et al. Point mutations and nucleotide insertions in the MDM2 zinc finger structure of human tumors. J Pathol 1997;182:54-61.
24. Sigalas I, Calvert AH, Anderson JJ, Neal DE, Lunec J. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nature Med 1996;2:912-7.
25. Matsumoto R, Tada M, Nozaki M, Zhang CL, Sawamura Y, Abe H. Short alternative splice transcripts of the mdm2 oncogene correlates to malignancy in human astrocytic neoplasms. Cancer Res 1998;58: 609-13.
26. Kraus A, Neff F, Behn M, Schuermann M, Muenkel K, Schlegel J. Expression of alternatively spliced MDM2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells. Int J Cancer 1999;80:930-4.
27. Enzinger FM, Weiss SW. General considerations. In: Enzinger FM, Weiss SW, editors. Soft tissue tumors. St. Louis, MO: Mosby, 1995: 1-18.
28. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
29. Biernat W, Kleihues P, Yonekawa Y, Ohgaki H. Amplification and Overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol 1997;56:180-5.
30. Taylor AC, Shu L, Danks MK, Poquette CA, Shetty S, Thayer MJ. et al. p53 Mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Med Pediatr Oncol 2000; 35:96-103.
31. Wall expression by UV-light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system. Mol Cell Biol 1998;18:1400-7.
32. Kaarniranta K, Elo M, Sirenen R, Lammi MJ, Goldring MB, Eriksson JE, et al. Hsp70 accumulation in chondrocytic cells exposed to high continuous hydrostatic pressure coincide with mRNA stabilization rather than transcriptional activity. Proc Natl Acad Sci U S A 1998; 95:2319-24.
33. Erondu NE, Nwankwo J, Zhong Y, Boes M, Dake B, Bar RS. Transcriptional and posttranscriptional regulation of insulin-like growth factor binding protein-3 by cyclic adenosine 3′,5′-monphosphate: messenger RNA stabilization is accompanied by decreased binding of a 42-kDa protein to a uridine-rich domain in the 3′-untranslated region. Mol Endocrinol 1999;13:495-504.
34. Brown CY, Mize GJ, Pineda M, George DL, Morris DR. Role of two upstream open reading frames in the translational control of oncogene mdm2. Oncogene 1999;18:5631-7.
35. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997;18:533-7.
36. Taubert H, Kappler M, Meye A, Bartel F, Schlott T, Lautenschläger C, et al. A MboII polymorphism in exon 11 of the human MDM2 gene in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibilty? Mutat Res 2000;456:39-44.
37. Maeda T, Hiranuma H, Jikko A. Differential expression of the splicing regulatory factor genes during two-step chemical transformation in a BALB/3T3-derived cell line, MT-5. Carcinogenesis 1999;20: 2341-4.
38. Goodison S, Tarin D. Clinical implications of anomalous CD44 gene expression in neoplasia. Front Biosci 1998;3:E89-E109.
39. Schmitt E, Paquet C, Beauchemin M, Dever-Bertrand J. Bertrand R. Characterization of Bax-sigma, a cell death-inducing isoform of Bax. Biochem Biophys Res Commun 2000;270:868-79.
40. Ejima Y, Yang L, Sasaki MS. Aberrant splicing of the ATM gene associated with shortening of the intronic mononucleotide tract in human colon tumor cell lines: a novel mutation target of microsatellite instability. Int J Cancer 2000;86:262-8.
41. Almog N, Goldfinger N, Rotter V. p53-Ddependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53. Oncogene 2000;19:3395-403.